The global hemophilia market was valued at USD 11.1 Billion in 2022 and is projected to reach USD 17.3 Billion by 2032, with a rapid compound annual growth rate (CAGR) of 4.9% during the forecast period. Factors such as the increasing prevalence of hemophilia, advancements in technology, and greater awareness and demand for prophylactic treatment contribute significantly to the growth of the...
English
العربية
Français
Español
Português
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt